Tools
ToolsMerinopoulos, Ioannis, Corballis, Natasha, Bhalraam, U., Natarajan, Rajkumar, Gunawardena, Tharusha, Reinhold, Johannes, Maart, Clint, Sawh, Chris, Sulfi, Sreekumar, Wistow, Trevor, Ryding, Alisdair, Gilbert, Tim, Vassiliou, Vassilios S. and Eccleshall, Simon C. (2026) Assessment of Paclitaxel Drug-Coated Balloon-Only Angioplasty for Multivessel Coronary Artery Disease. Journal of Clinical Medicine, 15 (1). ISSN 2077-0383
Full text not available from this repository. (Request a copy)Abstract
Background: There are limited data about the use of drug-coated balloon (DCB)-only angioplasty for multivessel coronary disease. Objectives: The aim of this study was to assess the safety and efficacy of DCB-only angioplasty as compared with second-generation drug-eluting stents (DESs) in patients undergoing multivessel angioplasty. Methods: We compared major adverse cardiovascular events (MACEs) in all patients undergoing multivessel angioplasty in our institution from 1 January 2015 until 15 November 2019, with either the DCB-only or DES-only strategy. The primary endpoint of our study was a MACE, including cardiovascular mortality, acute coronary syndrome, target lesion revascularisation, stroke, or major bleeding. Data were analysed using Cox regression models, Kaplan–Meier estimator plots, and propensity score matching. Results: A total of 159 consecutive patients treated with DCB-only angioplasty and 222 consecutive patients treated with DES-only angioplasty were identified. The majority of the vessels treated were large vessels (>3 mm). After a median follow-up of 4 years, a total of 52 (33%) patients in the DCB and 73 (33%) patients in the DES group encountered a MACE (p = 0.97). The results did not change following propensity score matching. On multivariate Cox regression analysis in the propensity score-matched cohort, atrial fibrillation [HR = 2.37, CI: (1.22–4.61), p = 0.011] and diabetes [HR = 1.71, CI: (1.13–2.60), p = 0.011] were the only independent adverse predictors of MACE. Conclusions: DCB-only angioplasty appears to be safe and efficient when compared to DES for multivessel angioplasty in terms of MACEs after a follow-up of 4 years.
| Item Type: | Article |
|---|---|
| Additional Information: | Data Availability Statement: Data can be made available following appropriate request to the corresponding author. |
| Uncontrolled Keywords: | drug coated balloon only angioplasty,drug eluting stent,multivessel angioplasty,medicine(all),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 03 Mar 2026 16:30 |
| Last Modified: | 08 Mar 2026 07:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/102156 |
| DOI: | 10.3390/jcm15010204 |
Actions (login required)
 |
View Item |